Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation

Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation

Pristimerin is a triterpenoid isolated from <em>Celastrus </em>and <em>Maytenus spp.</em><em> </em>that<em> </em>has been shown to possess a variety of biological activities, including ant...

Full description

Bibliographic Details
Main Authors: Luyong Zhang, Zhenzhou Jiang, Wei Shi, Han Li, Lixin Sun, Xianmin Mu
Format: Article
Language:English
Published: MDPI AG 2012-06-01
Series:Molecules
Subjects:
pristimerin
angiogenesis
cancer
KDR/Flk-1
AKT/mTOR
Online Access:http://www.mdpi.com/1420-3049/17/6/6854

Internet

http://www.mdpi.com/1420-3049/17/6/6854

Similar Items